SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016236
Filing Date
2024-05-13
Accepted
2024-05-13 16:11:25
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20240331_10q.htm   iXBRL 10-Q 1339094
2 EXHIBIT 31.1 ex_634995.htm EX-31.1 16248
3 EXHIBIT 31.2 ex_634996.htm EX-31.2 16684
4 EXHIBIT 32.1 ex_634997.htm EX-32.1 12849
10 a01.jpg GRAPHIC 73750
  Complete submission text file 0001437749-24-016236.txt   6892723

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240331.xsd EX-101.SCH 61388
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20240331_cal.xml EX-101.CAL 48789
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240331_def.xml EX-101.DEF 425853
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240331_lab.xml EX-101.LAB 368651
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240331_pre.xml EX-101.PRE 456898
79 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240331_10q_htm.xml XML 1026264
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 24939173
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)